A state-of-the-art drug testing laboratory in Himachal Pradesh's BBN industrial belt, costing over Rs 30 crore, has shown minimal impact on drug quality a year after its commissioning. Despite high operational costs and testing fees, substandard drugs from the region continue to surface, with Himachal accounting for nearly 31% of national failures in a recent period. The lab, outsourced to a private agency, tests thousands of samples annually but has not significantly improved compliance among manufacturers.